Cognitive dysfunction in multiple sclerosis: Assessment, imaging, and risk factors

Journal of Rehabilitation Research and Development

Volumn 43, Issue 1, 2006, Pages 63-72

  Wallin, Mitchell T ^a,b,c   Wilken, Jeffrey A ^a,c,d   Kane, Robert ^c,d  

^a DEPARTMENT OF VETERANS AFFAIRS   (United States)

^b GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d UNIVERSITY OF MARYLAND   (United States)

Author keywords

Central nervous system; Cognition; Cognitive testing; Epidemiology; Imaging; MRI; Multiple sclerosis; Neuropsychology; Outcome; Risk factors

Indexed keywords

DATA PROCESSING; DISEASE CONTROL; MEDICAL IMAGING; NEUROLOGY; RISK ASSESSMENT;

COGNITIVE DYSFUNCTION; MULTIPLE SCLEROSIS (MS); RISK FACTORS;

PATIENT TREATMENT;

APTITUDE TEST; ATTENTION; BRAIN DAMAGE; CENTRAL NERVOUS SYSTEM; COGNITIVE DEFECT; DAILY LIFE ACTIVITY; DISEASE COURSE; EMPLOYMENT; HEALTH CARE MANAGEMENT; HUMAN; HUMAN RELATION; IMAGING SYSTEM; INFORMATION PROCESSING; MEMORY; MULTIPLE SCLEROSIS; PRIORITY JOURNAL; PSYCHOLOGIC ASSESSMENT; REVIEW; RISK FACTOR; SCREENING TEST;

ADULT; AGE DISTRIBUTION; COGNITION DISORDERS; COMORBIDITY; DIAGNOSTIC IMAGING; FEMALE; HUMANS; INCIDENCE; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; NEUROPSYCHOLOGICAL TESTS; PROGNOSIS; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SEX DISTRIBUTION; VETERANS;

EID: 33745312709     PISSN: 07487711     EISSN: 07487711     Source Type: Journal    
DOI: 10.1682/JRRD.2004.09.0120     Document Type: Review

References (51)

1. Rao SM, Leo GJ, Bernardin L, Unverzagt F. Cognitive dysfunction in multiple sclerosis. I. Frequency, patterns, and prediction. Neurology. 1991;41(5):685-91.
2. Turner MA, Moran NF, Kopelman MD. Subcortical dementia. Br J Psychiatry. 2002;180:148-51.
3. Rao SM, Leo GJ, Ellington L, Nauertz T, Bernardin L, Unverzagt F. Cognitive dysfunction in multiple sclerosis. II. Impact on employment and social functioning. Neurology. 1991;41(5):692-96.
4. Wishart H, Sharpe D. Neuropsychological aspects of multiple sclerosis: a quantitative review. J Clin Exp Neuropsychol. 1997;19(6):810-24.
5. Amato MP, Ponziani G, Siracusa G, Sorbi S. Cognitive dysfunction in early-onset multiple sclerosis: a reappraisal after 10 years. Arch Neurol. 2001;58(10):1602-6.
6. Wilken JA, Wallin MT, Sullivan CL, Usiskin JB, Kane RL, Simsarian J, Saunders C, Mikszewski J, Rossman H, Lawson S, Kerr D, Crayton H, Quig ME. Combination therapy (Provigil + Avonex) in the treatment of attention problems in patients with relapsing-remitting MS [abstract]. Neurology. 2004;64(Suppl 1):P05.141.
7. Fischer JS, Priore RL, Jacobs LD, Cookfair DL, Rudick RA, Herndon RM, Richert JR, Salazar AM, Goodkin DE, Granger CV, Simon JH, Grafman JH, Lezak MD, O'Reilly Hovey KM, Perkins KK, Barilla-Clark D, Schacter M, Shucard DW, Davidson AL, Wende KE, Bourdette DN, Kooijmans-Coutinho MF. Neuropsychological effects of interferon β-1a in relapsing multiple sclerosis. Multiple Sclerosis Collaborative Research Group. Ann Neurol. 2000;48(6):885-92.
8. Geisler MW, Sliwinski M, Coyle PK, Masur DM, Doscher C, Krupp LB. The effects of amantadine and pemoline on cognitive functioning in multiple sclerosis. Arch Neurol. 1996;53(2):185-88.
9. Greene YM, Tariot PN, Wishart H, Cox C, Holt CJ, Schwid S, Noviasky J. A 12-week, open trial of donepezil hydrochloride in patients with multiple sclerosis and associated cognitive impairments. J Clin Psychopharmacol. 2000;20(3):350-56.
10. Fischer JS. Cognitive impairment in multiple sclerosis. In: Cook SD, editor. Handbook of multiple sclerosis. 3rd ed. New York (NY): Marcel Dekker, Inc; 2001. p. 233-56.
11. Heaton RK, Nelson LM, Thompson DS, Burks JS, Franklin GM. Neuropsychological findings in relapsing-remitting and chronic-progressive multiple sclerosis. J Consult Clin Psychol. 1985;53(1):103-10.
12. Arnett PA, Higginson CI, Voss WD, Randolph JJ, Grandey AA. Relationship between coping, cognitive dysfunction and depression in multiple sclerosis. Clin Neuropsychol. 2002;16(3):341-55.
13. Romani A, Bergamaschi R, Candeloro E, Alfonsi E, Callieco R, Cosi V. Fatigue in multiple sclerosis: multidimensional assessment and response to symptomatic treatment. Mult Scler. 2004;10(4):462-68.
14. Tartaglia MC, Narayanan S, Francis SJ, Santos AC, De Stefano N, Lapierre Y, Arnold DL. The relationship between diffuse axonal damage and fatigue in multiple sclerosis. Arch Neurol. 2004;61(2):201-7.
15. Richter P, Werner J, Heerlein A, Kraus A, Sauer H. On the validity of the Beck Depression Inventory. A review. Psychopathology. 1998;31(3):160-68.
16. Krupp LB, LaRocca NG, Muir-Nash J, Steinberg AD. The fatigue severity scale. Application to patients with multiple sclerosis and systemic lupus erythematosus. Arch Neurol. 1989;46(10):1121-23.
17. Cummings JL, Benson DF. Dementia: a clinical approach. Boston (MA): Butterworth; 1983.
18. Zarei M, Chandran S, Compston A, Hodges J. Cognitive presentation of multiple sclerosis: evidence for a cortical variant. J Neurol Neurosurg Psychiatry. 2003;74(7):872-77.
19. Rao SM. Cognitive function in patients with multiple sclerosis: impairment and treatment. Int J MS Care. 2004;4(1):9-22.
20. Benedict RH, Fischer JS, Archibald CJ, Arnett PA, Beatty WW, Bobholz J, Chelune GJ, Fisk JD, Langdon DW, Caruso L, Foley F, LaRocca NG, Vowels L, Weinstein A, DeLuca J, Rao SM, Munschauer F. Minimal neuropsychological assessment of MS patients: a consensus approach. Clin Neuropsychol. 2002;16(3):381-97.
21. Wilken JA, Kane RL, Sullivan CL, Wallin MT, Usiskin JB, Quig ME, Simsarian J, Saunders C, Crayton H, Mandler R, Kerr D, Reeves DL, Fuchs K, Manning C, Keller M. The utility of computerized neuropsychological assessment of cognitive dysfunction in patients with relapsing-remitting multiple sclerosis. Mult Scler. 2003;9(2):119-27.
22. Reeves DL, Winter K, LaCour S, Raynsford K, Kay G, Elsmore T, Hegge FW. Automated neuropsychological assessment metrics documentation. Vol I. Test administration guide. Washington (DC): Office of Military Performance Assessment Technology; 1992.
23. Kane RL, Reeves DL. Computerized test batteries. In: Horton A, Wedding D, Webster J, editors. The neuropsychology handbook. New York (NY): Springer; 1997.
24. Bielekova B, Martin R. Development of biomarkers in multiple sclerosis. Brain. 2004;127(Pt 7):1463-78.
25. Rao SM, Leo GJ, Haughton VM, St Aubin-Faubert P, Bernardin L. Correlation of magnetic resonance imaging with neuropsychological testing in multiple sclerosis. Neurology. 1989;39(2 Pt 1):161-66.
26. Comi G, Rovaris M, Falautano M, Santuccio G, Martinelli V, Rocca MA, Possa F, Leocani L, Paulesu E, Filippi M. A multiparametric MRI study of frontal lobe dementia in multiple sclerosis. J Neurol Sci. 1999;171(2):135-44.
27. Rovaris M, Filippi M, Falautano M, Minicucci L, Rocca MA, Martinelli V, Comi G. Relation between MR abnormalities and patterns of cognitive impairment in multiple sclerosis. Neurology. 1998;50(6):1601-8.
28. Lazeron RH, Langdon DW, Filippi M, Van Waesberghe JH, Stevenson VL, Boringa JB, Origgi D, Thompson AJ, Falautano M, Polman CH, Barkhof F. Neuropsychological impairment in multiple sclerosis patients: the role of (juxta)cortical lesion on FLAIR. Mult Scler. 2000;6(4):280-85.
29. Zivadinov R, De Masi R, Nasuelli D, Bragadin LM, Ukmar M, Pozzi-Mucelli RS, Grop A, Cazzato G, Zorzon M. MRI techniques and cognitive impairment in the early phase of relapsing-remitting multiple sclerosis. Neuroradiology. 2001;43(4):272-78.
30. Zivadinov R, Sepcic J, Nasuelli D, De Masi R, Bragadin LM, Tommasi MA, Zambito-Marsala S, Moretti R, Bratina A, Ukmar M, Pozzi-Mucelli RS, Grop A, Cazzato G, Zorzon M. A longitudinal study of brain atrophy and cognitive disturbances in the early phase of relapsing-remitting multiple sclerosis. J Neurol Neurosurg Psychiatry. 2001;70(6):773-80.
31. Benedict RH, Carone DA, Bakshi R. Correlating brain atrophy with cognitive dysfunction, mood disturbances, and personality disorder in multiple sclerosis. J Neuroimaging. 2004;14(3 Suppl):S36-45.
32. Audoin B, Ibarrola D, Ranjeva JP, Confort-Gouny S, Malikova I, Ali-Cherif A, Pelletier J, Cozzone P. Compensatory cortical activation observed by fMRI during a cognitive task at the earliest stage of MS. Hum Brain Mapp. 2003;20(2):51-58.
33. Rovaris M, Iannucci G, Falautano M, Possa F, Martinelli V, Comi G, Filippi M. Cognitive dysfunction in patients with mildly disabling relapsing-remitting multiple sclerosis: an exploratory study with diffusion tensor MR imaging. J Neurol Sci. 2002;195(2):103-9.
34. Pan JW, Krupp LB, Elkins LE, Coyle PK. Cognitive dysfunction lateralizes with NAA in multiple sclerosis. Appl Neuropsychol. 2001;8(3):155-60.
35. Camp SJ, Stevenson VL, Thompson AJ, Miller DH, Borras C, Auriacombe S, Brochet B, Falautano M, Filippi M, Herisse-Dulo L, Montalban X, Parrcira E, Polman CH, De Sa J, Langdon DW. Cognitive function in primary progressive and transitional progressive multiple sclerosis: a controlled study with MRI correlates. Brain. 1999;122(Pt 7):1341-48.
36. Oliveri RL, Cittadella R, Sibilia G, Manna I, Valentino P, Gambardella A, Aguglia U, Zappia M, Romeo N, Andreoli V, Bono F, Caracciolo M, Quattrone A. APOE and risk of cognitive impairment in multiple sclerosis. Acta Neurol Scand. 1999;100(5):290-95.
37. Thornton AE, Raz N. Memory impairment in multiple sclerosis: a quantitative review. Neuropsychology. 1997;11(3):357-66.
38. Comi G, Filippi M, Martinelli V, Campi A, Rodegher M, Alberoni M, Sirabian G, Canal N. Brain MRI correlates of cognitive impairment in primary and secondary progressive multiple sclerosis. J Neurol Sci. 1995;132(2):222-27.
39. Beatty WW, Goodkin DE, Monson N, Beatty PA. Cognitive disturbances in patients with relapsing-remitting multiple sclerosis. Arch Neurol. 1989;46(10):1113-19.
40. McIntosh-Michaelis SA, Roberts MH, Wilkinson SM, Diamond ID, McLellan DL, Martin JP, Spackman AJ. The prevalence of cognitive impairment in a community survey of multiple sclerosis. Br J Clin Psychol. 1991;30(Pt 4):333-48.
41. Honig LS, Ramsay RE, Sheremata WA. Event-related potential P300 in multiple sclerosis. Relation to magnetic resonance imaging and cognitive impairment. Arch Neurol. 1992;49(1):44-50.
42. Newton MR, Barrett G, Callanan MM, Towell AD. Cognitive event-related potentials in multiple sclerosis. Brain. 1989;112(Pt 6):1637-60.
43. Weinstock-Guttman B, Jacobs LD, Brownscheidle CM, Baier M, Rea DF, Apatoff BR, Blitz KM, Coyle PK, Frontera AT, Goodman AD, Gottesman MH, Herbert J, Holub R, Lava NS, Lenihan M, Lusins J, Mihai C, Miller AE, Perel AB, Snyder DH, Bakshi R, Granger CV, Greenberg SJ, Jubelt B, Krupp L, Munschauer FE, Rubin D, Schwid S, Smiroldo J, New York State Multiple Sclerosis Consortium. Multiple sclerosis characteristics in African American patients in the New York State Multiple Sclerosis Consortium. Mult Scler. 2003;9(3):293-98.
44. Feinstein A, Kartsounis LD, Miller DH, Youl BD, Ron MA. Clinically isolated lesions of the type seen in multiple sclerosis: a cognitive, psychiatric, and MRI follow-up study. J Neurol Neurosurg Psychiatry. 1992;55(10):869-76.
45. Kujala P, Portin R, Ruutiainen J. The progress of cognitive decline in multiple sclerosis. A controlled 3-year follow-up. Brain. 1997;120(Pt 2):289-97.
46. Piras MR, Magnano I, Canu ED, Paulus KS, Satta WM, Soddu A, Conti M, Achene A, Solinas G, Aiello I. Longitudinal study of cognitive dysfunction in multiple sclerosis: neuropsychological, neuroradiological, and neurophysiological findings. J Neurol Neurosurg Psychiatry. 2003;74(7):878-85.
47. Hohol MJ, Guttmann CR, Orav J, Mackin GA, Kikinis R, Khoury SJ, Jolesz FA, Weiner HL. Serial neuropsychological assessment and magnetic resonance imaging analysis in multiple sclerosis. Arch Neurol. 1997;54(8):1018-25.
48. Bennett DA, Wilson RS, Schneider JA, Evans DA, Beckett LA, Aggarwal NT, Barnes LL, Fox JH, Bach J. Natural history of mild cognitive impairment in older persons. Neurology. 2002;59(2):198-205.
49. Amato MP, Ponziani G, Pracucci G, Bracco L, Siracusa G, Amaducci L. Cognitive impairment in early-onset multiple sclerosis. Pattern, predictors, and impact on everyday life in a 4-year follow-up. Arch Neurol. 1995;52(2):168-72.
50. Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an Expanded Disability Status Scale (EDSS). Neurology. 1983;33(11):1444-52.
51. Morris JC. Dementia update 2003. Alzheimer Dis Assoc Disord. 2003;17(4):245-58.